NM_031229.4:c.1390C>T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_031229.4(RBCK1):​c.1390C>T​(p.Arg464Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000254 in 1,612,410 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R464G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00018 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00026 ( 0 hom. )

Consequence

RBCK1
NM_031229.4 missense

Scores

7
11

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 2.86

Publications

4 publications found
Variant links:
Genes affected
RBCK1 (HGNC:15864): (RANBP2-type and C3HC4-type zinc finger containing 1) Enables several functions, including identical protein binding activity; protein sequestering activity; and ubiquitin binding activity. Involved in several processes, including T cell receptor signaling pathway; cellular protein metabolic process; and regulation of DNA-binding transcription factor activity. Part of LUBAC complex. Implicated in glycogen storage disease. [provided by Alliance of Genome Resources, Apr 2022]
TBC1D20 (HGNC:16133): (TBC1 domain family member 20) This gene encodes a protein that belongs to a family of GTPase activator proteins of Rab-like small GTPases. The encoded protein and its cognate GTPase, Rab1, bind the nonstructural protein 5A (NS5A) of the hepatitis C virus (HCV) to mediate viral replication. Depletion of this protein inhibits replication of the virus and HCV infection. Mutations in this gene are associated with Warburg micro syndrome 4. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2014]
TBC1D20 Gene-Disease associations (from GenCC):
  • Warburg micro syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • Warburg micro syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.26337743).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_031229.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RBCK1
NM_031229.4
MANE Select
c.1390C>Tp.Arg464Cys
missense
Exon 11 of 12NP_112506.2Q9BYM8-1
RBCK1
NM_001410770.1
c.1441C>Tp.Arg481Cys
missense
Exon 11 of 12NP_001397699.1A0A8V8TMZ2
RBCK1
NM_006462.6
c.1264C>Tp.Arg422Cys
missense
Exon 10 of 11NP_006453.1Q9BYM8-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RBCK1
ENST00000356286.10
TSL:1 MANE Select
c.1390C>Tp.Arg464Cys
missense
Exon 11 of 12ENSP00000348632.6Q9BYM8-1
RBCK1
ENST00000353660.7
TSL:1
c.1264C>Tp.Arg422Cys
missense
Exon 10 of 11ENSP00000254960.5Q9BYM8-3
RBCK1
ENST00000382181.2
TSL:1
n.*410C>T
non_coding_transcript_exon
Exon 9 of 10ENSP00000371616.3Q9BYM8-4

Frequencies

GnomAD3 genomes
AF:
0.000184
AC:
28
AN:
152020
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000382
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000181
AC:
45
AN:
248546
AF XY:
0.000178
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000406
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000260
Gnomad OTH exome
AF:
0.000329
GnomAD4 exome
AF:
0.000262
AC:
382
AN:
1460390
Hom.:
0
Cov.:
31
AF XY:
0.000244
AC XY:
177
AN XY:
726498
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33468
American (AMR)
AF:
0.000335
AC:
15
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39694
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52264
Middle Eastern (MID)
AF:
0.000535
AC:
3
AN:
5604
European-Non Finnish (NFE)
AF:
0.000317
AC:
353
AN:
1111936
Other (OTH)
AF:
0.000149
AC:
9
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
21
43
64
86
107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000184
AC:
28
AN:
152020
Hom.:
1
Cov.:
32
AF XY:
0.000162
AC XY:
12
AN XY:
74242
show subpopulations
African (AFR)
AF:
0.0000242
AC:
1
AN:
41386
American (AMR)
AF:
0.0000655
AC:
1
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000382
AC:
26
AN:
67988
Other (OTH)
AF:
0.00
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000268
Hom.:
1
Bravo
AF:
0.000212
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000124
AC:
15
EpiCase
AF:
0.000109
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
Polyglucosan body myopathy type 1 (3)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.029
T
BayesDel_noAF
Uncertain
0.040
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.56
D
Eigen
Benign
-0.083
Eigen_PC
Benign
0.11
FATHMM_MKL
Benign
0.74
D
LIST_S2
Uncertain
0.97
D
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.26
T
MetaSVM
Benign
-0.59
T
MutationAssessor
Benign
0.36
N
PhyloP100
2.9
PrimateAI
Uncertain
0.60
T
PROVEAN
Uncertain
-3.4
D
REVEL
Uncertain
0.47
Sift
Benign
0.16
T
Sift4G
Benign
0.20
T
Polyphen
0.041
B
Vest4
0.43
MVP
0.80
MPC
0.59
ClinPred
0.11
T
GERP RS
5.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.47
gMVP
0.63
Mutation Taster
=65/35
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145423115; hg19: chr20-409676; COSMIC: COSV62292313; COSMIC: COSV62292313; API